Dr. Robert A. Nagourney, MDAug 14, 20233 min read“New” Immune Therapy Active in Late-Stage Cancer PatientsHere in 2023, we suddenly discover that TIL cells are highly active against cancer, but it was Steven Rosenberg who first described it.
